The recently introduced technique of sentinel lymph node dissection (SLND)
may replate complete axillary lymph node dissection for axillary staging of
early breast cancer. Successful SLND is predicated on meticulous delineati
on of the lymphatic pathway and sentinel node(s). Currently employed lympha
tic mapping materials include vital blue dyes and radioactive tracers. Tech
niques of intraoperative lymphatic mapping and SLND using dye, tracer, or b
oth have high success rates in the hands of experienced investigators, but
their routine and widespread use awaits resolution of questions about the t
iming, dose, and type of radioactive tracer; the optimal lymphatic mapping
technique; indications and contraindications for SLND; and certification of
qualified surgeons, pathologists, and nuclear medicine physicians.